CMEonHIV.com is dedicated to providing online CME presentations (slides with voiceover) on HIV/AIDS for healthcare professionals given by local and international experts to keep you up-to-date on the ongoing developments in the field.
Biography
Dr. Julio Montaner
Current Position
Professor of Medicine and Chair in AIDS Research, The University of British Columbia
Primary Areas of Interest
HIV/AIDS
Antiretroviral therapy
Respiratory complications of HIV infection
Salvage therapy in HIV/AIDS
Multiple drug rescue therapy in HIV/AIDS
Lipodystrophy and metabolic disorders associated with HIV/AIDS
Initiation of treatment in HIV/AIDS
Treatment interruptions in HIV/AIDS
Therapeutic Drug Monitoring (TMD) in HIV/AIDS
Pharmacology and Drug Interactions in HIV/AIDS
Medical Training
University of Beunos Aires, Argentina
Internal Medicine and Respiratory Medicine, University of British Columbia
Post-Graduate Training
Universidad de Beunos Aires, (UBA), Rotating Internship
Hospital "Cosme Argerich", UBA, Resident
UBC- Department of Medicine, Resident III - IV
UBC-Respiratory Division, Clinical Fellow
UBC- Department of Medicine, Senior Resident
UBC-Department of Medicine/SPH, Chief Resident
Current Boards or Associations
Scientific Committee, bi-annual International Conference on HIV Therapy
Co-Chair, Annual International Workshop on Salvage Therapy
Member, V/RHB HIV Surveillance, Epidemiology and Research Review Committee
Member, Vaccine and Immunotherapeutics Committee
Chair, Site Selection Committee, International AIDS Society
Co-Chair, Track B, 1st IAS Conference on HIV Pathogenesis & Treatment
Member, Scientific Committee, 1st IAS Conference on HIV Pathogenesis & Treatment
Memberships
International AIDS Society (USA) Expert Panel on Antiretroviral Therapies
Treasurer, Canadian Association for HIV Research
Council on the International AIDS Society
Member, International Association of Physicians in AIDS Care
Recent Publications
- Montaner JSG, Hill A, Acosta E. Practical implications for the interpretation of minimum plasma concentration/inhibitory concentration ratios. Lancet 2001; 357:1438-40.
- Harrigan RP, Montaner JSG, Wegner SA, Verbiest W, Miller V, Wood R, Larder BA. World-wide variation in HIV-1 phenotypic susceptibility in untreated individuals: biologically relevant values for resistance testing. AIDS 2001;15:1671-1677.
- Hogg RS, Yip B, Chan KJ, Wood E, Craib KJP, O'Shaughnessy MV, Montaner JSG. Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy. JAMA 2001;286(20):2568-2577.
- Montaner JSG, O'Shaughnessy MV, Schechter MT. Industry-sponsored clinical research: a double-edged sword. Lancet 2001;358:1893-95.
- Hogg RS, Havlir D, Miller V, Montaner JSG. To stop or not to stop: This is the question, but what is the answer? AIDS 2002;16:1-3
Honours/Awards
1987-1997: National Health Research Scholar, Pathogenesis and Treatment of HIV and Related Diseases,
NHRDP, Health and Welfare, Ottawa.
1995: The Louis Pasteur Award for Excellence in Clinical Medicine in the Fight Against AIDS
1996: The Martin Hoffman Award for Excellence in Research, Department of Medicine, UBC
2002: Boehringer Ingelheim - Distinguished Researcher Award
List of presentations from this healthcare provider available on CMEonHIV :
USER ACKNOWLEDGES AND AGREES THAT ALL DECISIONS MADE WITH THE ASSISTANCE OR USE OF THE SOFTWARE AND/OR THE WEBSITE AND/OR BASED ON CONTENT FOUND HEREIN WILL BE EXCLUSIVELY THE RESPONSIBILITY OF THE USER.
